粪便细菌疗法
萧条(经济学)
医学
移植
微生物群
重症监护医学
重性抑郁障碍
便秘
精神科
内科学
生物信息学
艰难梭菌
抗生素
生物
认知
微生物学
经济
宏观经济学
作者
Jessica P. K. Doll,Jorge F. Vázquez‐Castellanos,Anna-Chiara Schaub,Nina Schweinfurth,Cedric Kettelhack,Else Schneider,Gulnara Yamanbaeva,Laura Mählmann,Serge Brand,Christoph Beglinger,Stefan Borgwardt,Jeroen Raes,André Schmidt,Undine E. Lang
标识
DOI:10.3389/fpsyt.2022.815422
摘要
Depression is a debilitating disorder, and at least one third of patients do not respond to therapy. Associations between gut microbiota and depression have been observed in recent years, opening novel treatment avenues. Here, we present the first two patients with major depressive disorder ever treated with fecal microbiota transplantation as add-on therapy. Both improved their depressive symptoms 4 weeks after the transplantation. Effects lasted up to 8 weeks in one patient. Gastrointestinal symptoms, constipation in particular, were reflected in microbiome changes and improved in one patient. This report suggests further FMT studies in depression could be worth pursuing and adds to awareness as well as safety assurance, both crucial in determining the potential of FMT in depression treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI